AXSM three-lens brief
Evidence-based stock research on AXSM. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Underperforming SPY by 11.1pp over 30 days. · Trading >3% below the 50-day MA — short-term weakness.
- Trading >3% below the 50-day MA — short-term weakness.
- Underperforming SPY by 11.1pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $285.42 — 35% above current (21 analysts).
- Negative free cash flow last quarterly (-$4.58M).
AXSM closed at $211.12 (+0.23%) as of 2026-09-11. Market cap: $11.06B. Price is below the 50-day MA and above the 200-day MA. Positives: analyst mean target $285.42 — 35% above current (21 analysts).. Concerns: trading >3% below the 50-day MA — short-term weakness.; underperforming SPY by 11.1pp over 30 days.. Last quarter: Revenue $218.38M, net income -$51.31M, free cash flow -$4.58M.
Why three lenses on AXSM, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AXSMacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/AXSM" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AXSM brief"></iframe>